ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1761

Rheumatoid Arthritis Inpatient Mortality: An Analysis of the National Inpatient Sample

Ehizogie Edigin1, Precious Eseaton2 and Augustine Manadan3, 1John H Stroger Jr. Hospital of Cook County, Chicago, IL, 2University of Benin Teaching Hospital, Benin, 3Cook County Hospital/Rush University Medical center, Chicago, IL

Meeting: ACR Convergence 2020

Keywords: rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid Arthritis (RA) is a chronic autoimmune disease with increased mortality. Little national-level data is available on inpatient mortality in RA patients. In this report, we use a large Unites States (U.S) population-based database to analyze the principal discharge diagnosis for RA patients experiencing inpatient mortality.

Methods: Data were abstracted from the National Inpatient Sample (NIS) Database. This is the largest inpatient hospitalization database in the U.S. It is a nationally representative sample of 20% of hospitalizations from approximately 1000 hospitals.  The numbers in the databases are weighted to optimize national estimates. The NIS was searched for hospitalizations in 2017 with an ICD-10 RA codes M05 and M06 as the principal or secondary diagnosis. The total number of RA discharges, number of in-hospital deaths, percentage of in-hospital deaths, length of stay (LOS), total hospital charges were recorded. The “principal discharge diagnosis” in RA patients experiencing in-hospital death was divided into 19 ICD 10 code categories.

Results: There were over 30 million discharges included in the 2017 NIS database. Of those, 565,440 hospitalizations were for patients aged 18 years or above, who had either a principal or secondary ICD 10 code for RA. 13,285 of these patients (2.35%) experienced in-hospital mortality. These patients were mainly female 70.19%, whites 64.85%, average age of 74.31 years, average LOS of 7.04 days and mean total hospital charges of $101,210. The top 5 principal discharge ICD 10 code categories in RA patients experiencing inpatient mortality in descending order of frequency were as follows (see table 1 and figure 1): infections 4810 (36.20%), cardiovascular 2605 (19.60%), respiratory  2045 (15.39%), digestive system 875 (6.59%), hematology/oncology 865 (6.51%). The most common principal diagnoses in RA patients with in-hospital mortality were sepsis, followed by acute and chronic hypoxic respiratory failure, aspiration pneumonitis, non-ST segment myocardial infarction, and acute kidney injury in descending order of frequency.

Conclusion: For adult RA patients experiencing in-hospital mortality, infections were the most common ICD 10 code category, and sepsis was the most common specific ICD 10 code principal diagnosis of hospitalization. Preventive measures, prompt diagnosis, and management of sepsis are needed to reduce the rate of inpatient mortality for RA patients.

Table 1: ICD-10 code admission category for Rheumatoid arthritis hospitalizations with inpatient mortality

Figure 1: Clustered column chart of ICD 10 admission category for RA hospitalizations with inpatient mortality


Disclosure: E. Edigin, None; P. Eseaton, None; A. Manadan, None.

To cite this abstract in AMA style:

Edigin E, Eseaton P, Manadan A. Rheumatoid Arthritis Inpatient Mortality: An Analysis of the National Inpatient Sample [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-inpatient-mortality-an-analysis-of-the-national-inpatient-sample/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-inpatient-mortality-an-analysis-of-the-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology